US Stock MarketDetailed Quotes

CERE Cerevel Therapeutics Holdings

Watchlist

42.900
+0.200+0.47%

Close Jul 19 16:00 ET

7.82BMarket Cap-15714P/E (TTM)

Cerevel Therapeutics Holdings Stock Forum

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US)$
$Amicus Therapeutics(FOLD.US)$
$Iovance Biotherapeutics(IOVA.US)$
$Arcellx(ACLX.US)$
$Nuvalent(NUVL.US)$
$Apogee Therapeutics(APGE.US)$
$Inhibrx(INBX.US)$
$Fusion Pharmaceuticals(FUSN.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Vaxcyte(PCVX.US)$
$Soleno Therapeutics(SLNO.US)$
$Medtronic(MDT.US)$
$Madrigal Pharmaceuticals(MDGL.US)$
...

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US)$
$BeiGene(BGNE.US)$
$ACADIA Pharmaceuticals(ACAD.US)$
$Madrigal Pharmaceuticals(MDGL.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Revolution Medicines(RVMD.US)$
$Kymera Therapeutics(KYMR.US)$
$AbCellera Biologics(ABCL.US)$
$Bicycle Therapeutics(BCYC.US)$
$Edgewise Therapeutics(EWTX.US)$
$Immunocore(IMCR.US)$
$Kodiak Sciences(KOD.US)$
$Roivant Sciences(ROIV.US)$
...

KallaShock Pan

Apr 29 03:03

Ticker Report in April

Ticker Report
$WIMI Evaluate Research reiterated a "buy" rating with $7 latest price target for WIMI Hologram Cloud(NASDAQ: WIMI)
$PACB Barclays Trims Pacific Biosciences of California (NASDAQ:PACB) Target Price to $3.00
$NFLX Netflix, Inc. (NASDAQ:NFLX) Receives $590.15 Consensus Target Price from Brokerages
$SNOW Brokerages Set Snowflake Inc. (NYSE:SNOW) Target Price at $202.50
$RCI Barclays Trims Rogers Communications (NYSE:RCI) Target Price to $46.00
$CERE Cerevel Thera...

Moomoo AI

Dec 7, 2023 12:40

Analysts believe AbbVie's early acquisition of Cerevel, despite high risks, could potentially yield high returns and avoid bidding wars if emraclidine's data is positive. It's also seen as a strategic move to enhance AbbVie's long-term pipelines.

AbbVie's $8.7 Billion Bet on Cerevel Is Risky but Smart, Analysts Say

Moomoo AI

Dec 7, 2023 07:56

Analyst Mohit Bansal opines AbbVie might favour purchasing Cerevel due to its perceived clean IP and daily dosing for its principal schizophrenia medication. He anticipates potential benefit from peak adjustments in sales surpassing $3B.

AbbVie – Cerevel M&A Deal Lifts Reviva, Karuna

Alvinnnnnnngenius

Nov 3, 2023 14:44

Alerted 22 hit 26

$Cerevel Therapeutics Holdings(CERE.US)$

Mooers Radar

Oct 23, 2023 00:32

ColumnsWeekly Insider Money Tracking: Directors of Cerevel Therapeutics Buy Close to $400 Million Worth of Stock

1 | Below is a look at the top insider trades with the biggest value in the past week.
Last week, the major shareholder of $Cerevel Therapeutics Holdings(CERE.US)$, Bain Capital Investors Llc, purchased 5,480,052 shares worth $125 million in a transaction dated October 16th. The other two principal shareholders, Koppel Adam and Gordon Christopher, also bought an equivalent amount of stock at ...